In total we have tested 38 EBV-transformed B cell lines covering 52 HLA serotypes, which represent more than 98% of HLA-A, B, and C in the Chinese population, accounting for almost half of the HCC patients worldwide (Figures 4B,C). The gene discussed is HLA-A; the disease is hepatocellular carcinoma.